comparemela.com

Latest Breaking News On - Mark schneyer - Page 1 : comparemela.com

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United-states
Canada
Japan
Kimberly-manhard
Jason-butler
Joel-beatty
David-hoang
Brendan-teehan
Elaine-kim
Parag-meswani
Carbidopa-levodopa-trxs
Kimberly-manhart

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q4 2023 Earnings Call Transcript

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q4 2023 Earnings Call Transcript February 27, 2024 ACADIA Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $0.28 EPS, expectations were $0.32. ACADIA Pharmaceuticals Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day […]

United-states
Canada
Japan
Japanese
Tessa-romero
Steve-davis
Mark-schneyer
Doug-williamson
Head-of-research
Japanese-regulatory-agency
Inflation-reduction
Medicare-part-d

Acadia Pharmaceuticals: New DAYBUE Drug Already Showing Signs Of Slowing (NASDAQ:ACAD)

Acadia Pharmaceuticals: New DAYBUE Drug Already Showing Signs Of Slowing (NASDAQ:ACAD)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Canada
Doug-williamson
Austind-kim
Mark-schneyer
Nasdaq
Pharmaceuticals-inc
Head-of-research
Full-year
Clinical-studies
Acadia-clinical-studies
Executive-vice-president
General-counsel

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q4 2023 Earnings Call Transcript

ACADIA Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $0.28 EPS, expectations were $0.32. ACADIA Pharmaceuticals Inc.

United-states
Japan
Toronto
Ontario
Canada
United-kingdom
American
Japanese
Mark-schneyer
Parag-meswani
Charles-duncan
Tessa-romero

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q3 2023 Earnings Call Transcript

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q3 2023 Earnings Call Transcript November 3, 2023 Operator: Good day ladies and gentlemen and welcome to ACADIA Pharmaceuticals Third Quarter 2023 Financial Results Conference Call. My name is Kathy and I will be your coordinator for today. At this time, all participants are in a listen-only mode. We will be […]

United-states
Doug-williamson
Mark-schneyer
Steve-davis
Head-of-research
Neuron-pharmaceuticals
Inflation-reduction-act
Diverse-countries
Dangerous-gangs
Acadia-pharmaceuticals
Aybue
Steve-davis

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.